About Evinacumab
Class: | Monoclonal antibody (PCSK9 inhibitor)
Use: | Treatment of homozygous familial hypercholesterolemia (HoFH) in adults and pediatric patients aged 12 years and older
Adult dose: | 15 mg/kg administered as an intravenous infusion once every 4 weeks
Pediatric dose: | 15 mg/kg administered as an intravenous infusion once every 4 weeks for patients aged 12 years and older
Side effects: | Injection site reactions, nasopharyngitis, headache, nausea, diarrhea
Contraindications: | Hypers
Drug Class
Monoclonal antibody (PCSK9 inhibitor)
Uses & Indications
Treatment of homozygous familial hypercholesterolemia (HoFH) in adults and pediatric patients aged 12 years and older
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Manufacturer & Packaging
Manufacturer: Ultragenyx Germany GmbH, Germany
Package Size
2.3ml Vial
Price & Supplier
Price in UAE: AED 34269.56
Dosage Information
Adult Dose
15 mg/kg administered as an intravenous infusion once every 4 weeks
Pediatric Dose
15 mg/kg administered as an intravenous infusion once every 4 weeks for patients aged 12 years and older
Side Effects
Injection site reactions, nasopharyngitis, headache, nausea, diarrhea
Contraindications & Precautions
Hypersensitivity to evinacumab or any component of the formulation
Important Warnings
Risk of hypersensitivity reactions; monitor for signs and symptoms of allergic reactions during and after infusion.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.